• Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Medical Equipment & Devices
  • Sub-Industry: Life Science Equipment


188.8800 USD 1.7700 0.93%

As of 20:10:00 ET on 10/29/2014.

Snapshot for Illumina Inc (ILMN)

Open: 190.0100 Day's Range: 185.6000 - 191.8400 Volume: 831,457
Previous Close: 190.6500 52wk Range: 91.0300 - 192.8700 1-Yr Rtn: +103.05%

Stock Chart for ILMN

No chart data available.
  • ILMN:US 188.8400
  • 1D
  • 1M
  • 1Y
Interactive ILMN Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for ILMN

Current P/E Ratio (ttm) 97.9880
Estimated P/E(12/2014) 71.8175
Relative P/E vs. SPX 5.5647
Earnings Per Share (USD) (ttm) 1.9276
Est. EPS (USD) (12/2014) 2.6300
Est. PEG Ratio 3.0141
Market Cap (M USD) 26,820.96
Shares Outstanding (M) 142.00
30 Day Average Volume 1,396,279
Price/Book (mrq) 21.0474
Price/Sale (ttm) 14.3383
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 01/28/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for ILMN

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for ILMN

Illumina, Inc. develops, manufactures and markets integrated systems for the large scale analysis of genetic variation and biological function. The Company provides a comprehensive line of products and services that currently serve the sequencing, genotyping and gene expression markets for genomic research centers, pharmaceutical companies, academic institutions and biotechnology companies.

Jay T FlatleyChief Executive OfficerFrancis A DesouzaPresident
Marc A StapleySenior VP/CFOMostafa RonaghiSenior VP/CTO
More Company Profile & Key Executives for ILMN

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Sponsored Links
sec ||= nil